Lineage Cell Therapeutics : FORM S-3-Registration Statements

As filed with the Securities and Exchange Commission on March 7, 2024


Registration No. 333-


UNITED STATES


SECURITIES...

Related Keywords

United States , Washington , California , State Of California , Tel Aviv , Israel , American , Georgea Samuel , Brianm Culley , , Exchange Commission , Roche Group , Roche Ltd , Lineage Cell Therapeutics Inc , Genentech Inc , Implications Of Beinga Smaller Reporting Company , Exchange Commission On , California Institute For Regenerative Medicine , Tel Aviv Stock Exchange , Genentech , Eterna Therapeutics Inc , Securities Exchange , Cell Therapeutics , Securities Act , Exchange Act , Certain Information , Can Find More Information , Lineage Cell Therapeutics , License Agreement , California Institute , Investigational New Drug , Oligodendrocyte Progenitor Cells , Spinal Cord Injury , Novel Device , Smaller Reporting Company , Securities Exchange Act , Sarbanes Oxley Act , Capital Stock Common Shares , Capital Stock Preferred Shares , Debt Securities , Annual Report , Financial Condition , Quarterly Report ,